Both in Pharmaceuticals
Context Therapeutics vs Pasithea Therapeutics
Over the past year CNTX returned −81.7% and KTTA returned −31.0%; their daily moves had a correlation of 0.06.
CNTX −81.7% KTTA −31.0%Growth of $1, one year, split-adjusted
| Metric | CNTX | KTTA |
|---|---|---|
| Price | $0.2057 | $0.5100 |
| Market cap | $18.9M | $17.0M |
| Today | +6.03% | −3.77% |
| 1 month | −36.1% | +14.1% |
| 6 months | −91.5% | −40.0% |
| Year to date | −86.0% | −60.5% |
| 1 year | −81.0% | −37.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $43.0M | $45.7M |
| Dividend yield | — | — |
| Volatility (60d) | 70.4% | 103.8% |
| Short % of float | 6.2% | 0.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).